ImmunoCellular Therapeutics, Ltd. 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Mar 24, 2015
Insider Transaction Report
Form 4
FRACTOR DAVID
Chief Financial Officer
Transactions
- Award
Common Stock
2015-03-20+35,000→ 35,000 total - Award
Stock Option (Rt to Buy)
2015-03-20+50,000→ 50,000 totalExercise: $0.57Exp: 2025-03-20→ Common Stock (50,000 underlying) - Award
Stock Option (Rt to Buy)
2015-03-20+50,000→ 50,000 totalExercise: $0.57Exp: 2025-03-20→ Common Stock (50,000 underlying)
Holdings
- 41,667(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Reflects the receipt of a restricted stock unit. Each restricted stock unit represents a contingent right to receive one (1) share of Immunocellular Therapeutics, Ltd. common stock. The restricted stock unit shall vest in full on the second anniversary of the grant date.
- [F2]Option shares shall vest in a series of 48 equal consecutive monthly installments commencing on April 13, 2015 until fully vested.
- [F3]Option shares shall become fully vested and immediately exercisable if the average daily closing price of Immunocellular Therapeutics, Ltd.'s common stock on the NYSE MKT during any 10 consecutive trading day period exceeds a closing $2.00 weighted average bid and ask price per share (as adjusted for any stock splits and the like).